VEGFA and type 2 diabetes mellitus: The key DM-associated KEGG pathways involved in these pharmacological activities included Type II diabetes mellitus and inflammatory and immune-related pathways such as the Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, VEGF signaling pathway, T cell receptor signaling pathway, Toll-like receptor signaling pathway, and Calcium signaling pathway.